Molecular Imaging: Page 24

PET imaging predicts long-term outcomes in Parkinson's disease

By Will Morton

PET brain imaging in individuals with early Parkinson's disease can show which patients are at higher risk of long-term effects, according to a study by researchers in Italy.

September 11, 2023

FAPI-PET/CT may improve treatment of cancer patients

By Will Morton

Gallium-68 (Ga-68) FAPI-PET/CT imaging -- a highly accurate experimental approach for detecting cancer -- may further improve outcomes for patients undergoing radiation therapy, according to a recent analysis by German researchers.

September 11, 2023

FDA clears Xeos Aura 10 PET-CT specimen imaging system

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has approved Xeos' Aura 10 PET-CT specimen imaging system for the operating room.

September 10, 2023

Eczacıbaşı-Monrol to expand Lu-177 production

By AuntMinnie.com staff writers

Turkish radiopharmaceutical company Eczacıbaşı-Monrol plans to expand its Lutetium-177 (Lu-177) production capacity.

September 10, 2023

PET/CT-based model predicts prostate cancer in the 'PSA grey zone'

By Will Morton

Combining PET/CT with traditional clinical risk factors can detect prostate cancer in cases considered borderline based on prostate-specific antigen (PSA) levels -- in other words, cases in the "PSA grey zone," according to a group in Hunan, China.

September 10, 2023

PET reveals link between heart health and brain metabolism

By Will Morton

A PET study suggests that maintaining cardiovascular health during midlife can help reduce the risk of neurodegenerative disease later in life, according to a group in Spain.

September 6, 2023

Telix touts studies at EANM 2023

By AuntMinnie.com staff writers

Telix Pharmaceuticals is highlighting studies set to be presented at the European Association of Nuclear Medicine meeting to be held September 9-13 in Vienna.

September 5, 2023

FDOPA-PET/CT predicts survival in patients with midgut NETs

By Will Morton

PET/CT imaging with F-18 fluorodopa (FDOPA) is an effective approach for detecting neuroendocrine tumors (NETs) -- and now the scans may be used to predict survival in patients with tumors in the midgut, according to researchers in France.

September 5, 2023

PET/CT and PET/MRI appear equivalent for diagnosing prostate cancer

By Will Morton

PET/CT and PET/MRI have gone head-to-head for detecting prostate cancer relapse in a review that included 37 clinical studies and 8,709 patients -- with PET/MRI taking a slight lead, according to a team in China.

August 31, 2023

Actinium to present three abstracts at SOHO 2023

By AuntMinnie.com staff writers

Radiotherapy developer Actinium Pharmaceuticals will present three abstracts accepted for poster presentation at the Society of Hematologic Oncology (SOHO) 2023 annual meeting in Houston, TX, between September 6 and 9.

August 30, 2023

TerraPower, PanTera sign agreement for Ac-225 production

By AuntMinnie.com staff writers

TerraPower Isotopes and PanTera signed a strategic collaboration that they say will increase the global availability of actinium-225 (Ac-225), a radioisotope that may prove able to treat a large variety of cancer indications.

August 30, 2023

PET reveals sex differences in early Alzheimer's disease

By Will Morton

Brain PET imaging shows that women with higher tau pathology in the temporal lobe have worse cognitive performance than men, according to a study published August 28 in Alzheimer's and Dementia.

August 29, 2023

Previous Page

Page 24 of 609

Next Page